OPCH Stock Analysis: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$19.81
-0.14 (-0.70%)
▼
5d:
-3.41%
30d:
-30.07%
90d:
-44.07%
BUY
HIGH Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Apr 30, 2026
0d
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OPCH trading at deep discount. Market pricing in -14.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: OPCH trading at deep discount. Market pricing in -14.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.17
Based on 4.9% avg growth
INTRINSIC VALUE TODAY
$24.94
20.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $19.81, which is considered oversold relative to its 30-day fair value range of $21.37 to $29.23. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.7) compared to its historical average (15.4). Remarkably, the market is currently pricing in an annual earnings decline of 14.3% over the next few years. This pessimistic expectation contrasts with the company's recent 3.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is in a strong downtrend. The price is currently testing key support at $19.34. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.18 (+46.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OPCH is in a strong downtrend. The price is currently testing key support at $19.34. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $29.18 (+46.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.37 -
$29.23
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.3% below Wall St target ($29.18)
Trading Range Analysis
30-Day Trading Range
$21.37 -
$29.23
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$19.34
Resistance Level
$21.93
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.71
Wall Street Target
$29.18
(+46.3%)
Revenue Growth (YoY)
1.3%
Earnings Growth (YoY)
3.4%
Profit Margin
3.6%
Valuation Discount vs History
-14.3% cheaper
PE vs Historical
9.7 vs 15.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-14.3%
(market-implied from PE analysis)
1-Year Target
$17.95
(-10%)
2-Year Target
$16.16
(-19%)
3-Year Target
$14.54
(-27%)
3-Yr Target (if PE normalizes)
(PE: 10→15)
$23.05
(+16%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 5.8%)
$53.57
(+169%)
Base:
(SPY PE: 9.7, Growth: 5.8%)
$23.61
(+18%)
Bear:
(PE: 8.3, Growth: 5.8%)
$20.07
(+1%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (10x PE) as earnings recover.
Trailing PE: 15.45 | Current EPS (TTM): $1.28
Bull Case
$34.91
(+75%)
Analyst growth 60.4%, PE expands to 17.0
Base Case
$31.73
(+59%)
Market implied 60.4%, PE stable at 15.5
Bear Case
$13.45
(-33%)
Severe decline -20.0%, PE contracts to 13.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.7 to 15.4
Stabilization Target:
$31.63
(+58.5%)
PE Expansion Potential:
+58.5%
Share & Embed Analysis
Last updated: May 15, 2026 10:11 AM ET
Data refreshes hourly during market hours. Next update: 11:11 AM
Data refreshes hourly during market hours. Next update: 11:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |
